Free Newsletter
Register for our Free Newsletters
Analysis, Inspection and Laboratory
Assisted/Independent Living
Clinical and Nursing Equipment
Design and Manufacture of Medical Equipment
Diagnostics Equipment, Monitoring and Test
Education, Training and Professional Services
Health Education and Patient Management
Health Estates Management
Healthcare Support and Information Services
Hygiene and Infection Control
IT and Communications in Healthcare
Medical Device Technology
Research and Development
Safety and Security
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone

Aperio aims to fuel expansion plans by raising $10.6m

Aperio Technologies : 01 June, 2007  (New Product)
Aperio Technologies has raised a further $10.6 million to finance the expansion of the company’s sales, marketing and operations to implement its clinical market strategy.
To date, the company has raised a total of $33 million in equity capital.
The latest round was co-led by Galen Partners, a Stamford, Connecticut based private equity firm specialising in healthcare investing, and Advanced Technology Ventures (ATV) a bi-coastal venture fund specialising in healthcare and technology investments. Other existing investors also participated.

'As the recognised leader in digital pathology, with an installed base of more than 250 systems in more than 23 countries, and customers that include half of the top 13 pharmaceutical companies and more than two thirds of the top 14 rated US hospitals, Aperio is well positioned to unlock this market', said Tom Rodgers, a principal at Advanced Technology Ventures and a former vice president of corporate strategy at McKesson.

'Based on the benefits derived by the existing customer base, including increased efficiency, cost savings, and improved patient care, we believe Aperio will continue to dominate and lead this space with its pivotal technology'.

Zubeen Shroff, general partner at Galen, commented that, 'Aperio has done a terrific job in scaling its operations to address increasing customer demand'.
'They have solidified their leadership position in this rapidly emerging market by having superior products, successful go to market strategies, and being relentless in their focus on customer's unmet needs'.

Added Dirk Soenksen, CEO of Aperio, 'The additional capital investment by our existing investor team is an exceptional vote of confidence in Aperio and its technology'.

'We have benefited greatly from their proven experience in building healthcare technology companies and look forward to continuing to lead the industry in the adoption of digital pathology'.

Bookmark and Share
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
   © 2012
Netgains Logo